VSEE VSEE HEALTH, INC.
Services-Health Services · OTC · SEC CIK 1864531 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.4%
TTM net income YoY81.1%
TTM EPS YoY96.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin39.8%
Operating margin-99.7%
Net margin-113.8%
FCF margin-58.5%
EBITDA margin-76.1%
Returns
ROE-1,345.0%
ROA-71.5%
ROIC (approx.)-403.4%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.15x
Current ratio0.40x
Interest coverage-5.60x
Cash quality & payout
Operating cash flow / net income0.51x
Accruals ratio-35.4%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $14.62M | $10.42M |
| Cost of revenue | $7.26M | $3.24M |
| Gross profit | $7.36M | $7.18M |
| SG&A expense | $10.04M | $6.55M |
| Operating income | -$9.58M | -$62.15M |
| Interest expense | $2.81M | $211,459 |
| Pretax income | -$14.64M | -$59.34M |
| Income tax | $68,426 | -$1.64M |
| Net income | -$14.71M | -$57.70M |
| EBITDA | -$7.00M | -$60.83M |
| EPS (basic) | -0.73 | -5.65 |
| EPS (diluted) | -0.73 | -5.65 |
| Weighted avg. shares (diluted) | 20.14M | 10.21M |
| Balance sheet | ||
| Cash & equivalents | $5.05M | $326,115 |
| Receivables | $2.24M | $1.72M |
| Current assets | $8.37M | $3.02M |
| PP&E, net | $294,987 | $680,242 |
| Goodwill | $4.92M | $4.92M |
| Intangibles | $8.79M | $10.99M |
| Total assets | $22.41M | $19.99M |
| Current liabilities | $16.24M | $19.01M |
| Short-term debt | $880,175 | $433,983 |
| Long-term debt | $593,941 | $593,941 |
| Total debt | $1.47M | $1.03M |
| Total liabilities | $16.96M | $20.01M |
| Shareholders' equity | $5.45M | -$18,488 |
| Net debt | -$3.58M | $701,809 |
| Shares outstanding | 414,995 | 16.30M |
| Cash flow statement | ||
| Operating cash flow | -$3.45M | -$5.79M |
| Capital expenditure | $29,928 | $55,267 |
| Free cash flow | -$3.48M | -$5.84M |
| Investing cash flow | -$29,928 | -$26,144 |
| Financing cash flow | $8.42M | $6.02M |
| Depreciation & amortization | $2.59M | $1.32M |
| Stock-based compensation | $1.12M | $896,537 |
| Share buybacks | $44 | $5,150 |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.